# bupivacaine hydrochloride

NDC: 72603-287
Generic name: bupivacaine hydrochloride
Labeler / Manufacturer: Northstar Rx LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: PERINEURAL
Marketing started: 20241216
Marketing ended: 20261117
FDA application: ANDA216039

## Active ingredients

- BUPIVACAINE HYDROCHLORIDE: 5 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72603-287"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72603-287
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=adadc041-8d5e-4bf8-a89b-e227729a880d